Concepedia

Susan Feyerabend

SF

47

Publications

6.9K

Citations

28

H-Index

2006

Active since

Affiliations

Institut Gustave Roussy(Current)

Royal Marsden Hospital

Institute of Cancer Research

University of Tübingen

Merck & Co., Inc., Rahway, NJ, USA (United States)

Susan Feyerabend is an author at Institut Gustave Roussy specializing in urology, medicine, and oncology.

Top concepts

Publications per year

2006–2023

47

Publications

47

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer

Karim Fizazi, NamPhuong Tran, Luis Fein et al. · New England Journal of Medicine · 2017 · 2.1K citations · Full text

Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial

Karim Fizazi, NamPhuong Tran, Luis Fein et al. · The Lancet Oncology · 2019 · 781 citations · Full text

, , +6

Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study

Emmanuel S. Antonarakis, Josep M. Piulats, Marine Gross‐Goupil et al. · Journal of Clinical Oncology · 2019 · 679 citations · Full text

Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer

Ronald de Wit, Johann S. de Bono, Cora N. Sternberg et al. · New England Journal of Medicine · 2019 · 634 citations · Full text

Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy

Alexander Haese, Alexandre de la Taille, Hendrik Van Poppel et al. · European Urology · 2008 · 449 citations

, , +9

Rows per page

1–5 of 47